Why the study?
Metabolic syndrome increases the risk of cardiovascular disease and type 2 diabetes and is highly prevalent in COPD, but variations by gender, diagnostic criteria, and disease severity warranted assessment.
Design
Systematic review and meta-analysis
Authors
Loading...
Supports integrated MetS screening in COPD to manage CV risk; extends prior estimates via large pooled analysis.
Metabolic syndrome is highly prevalent (37%) among patients with COPD, highlighting the need for early detection and integrated care to manage cardiovascular risk.
Alrabbaie et al. (2025) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: